Abstract:Pathological mechanisms in the affected synovial joints in rheumatoid arthritis (RA) and factors contributing to synovial histological heterogeneity, which may impact treatment outcomes, remain largely unexplored at the protein level. Mapping the proteomic landscape of RA-affected synovial tissue (ST) and identifying determinants of synovial pathotypes could provide insights into RA’s pathological mechanisms, identify new therapeutic targets, and pave the way for personalized medicine options.To map the proteomic landscape and dysregulated biological pathways in ST and plasma at multiple stages of RA. Through this investigation, the study also aims to identify the molecular and cellular determinants of synovial histological pathotypes in early untreated RA patients.ST and matched plasma samples from patients with early untreated RA (ERA) (n = 20) and longstanding RA (LRA) (n = 20), as well as healthy controls (HC) (n = 16) were collected at baseline and at six months follow-up (RA patients only). ST biopsies were collected from the wrist via an ultrasound-guided synovial biopsy procedure (RA patients), or via arthroscopic guidance (HC). Samples were then characterized using discovery proteomics profiling. Comparisons were made between HC versus ERA or LRA at both timepoints, and proteins were regarded as differentially abundant at 5% FDR and a log2-fold change ±2.0 (ST proteins) or ±1.5 (plasma proteins). Next, the molecular and cellular determinants of synovial histological pathotypes were identified in untreated ERA patients by integrating the ST proteome, plasma proteome, Krenn synovitis score, number of circulating immune cells and scores of CD3 (T cells), CD20 (B cells), CD68 (Macrophages) and CD138 (Plasma cells) synovial immune infiltration.335 plasma proteins and 3416 ST proteins were identified and quantified.Plasma proteins: CRP and SAA1 were overabundant in ERA compared to HC at baseline, but no proteins were differentially abundant in ERA compared to HC at follow-up (Figure 1 A-B). CRP was overabundant in LRA compared to HC at both timepoints (Figure 1 C-D).Synovial tissue proteins: In ERA patients 243 proteins were differentially abundant at baseline, but only 114 were differentially abundant at follow-up (Figure 1 E-F). In LRA patients, 216 and 284 proteins were differentially abundant at baseline and follow-up, respectively (Figure 1 G-H). Largely the same biological processes were dysregulated in ERA at baseline and in LRA at both timepoints. However, biological processes related to complement cascade, acute inflammatory response, scavenging of heme from plasma among others, tended to be less dysregulated in ERA patients at follow-up. Finally, data integration identified proteomic and cellular signatures underlying synovial pathotypes, that suggests the difference between lymphoid, myeloid, and fibroid pathotypes is a continuous spectrum that is linearly modellable. Proteins involved in negative regulation of: peptidase/protease activity, hemostasis and wound healing were underabundant in the lymphoid pathotype compared to the fibroid pathotype and to a lesser degree, the myeloid pathotype. Proteins that were involved in various aspects of antibody production were overabundant in the lymphoid pathotype compared to the fibroid pathotype and to a lesser degree, the myeloid pathotype.Figure 1.Comparison between plasma and synovial tissue proteomes of early untreated rheumatoid arthritis patients (ERA) or longstanding rheumatoid arthritis (LRA) at baseline or follow-up versus healthy controls.The study revealed new insights into the proteomic landscape of the synovium in RA, elucidating the pathological mechanisms occurring in the synovium at different stages of disease. Additionally, the study identified a linear proteomic and cellular difference between the lymphoid, myeloid, and fibroid synovial pathotypes in untreated ERA patients, rather than distinct signatures for each pathotype.NIL.NIL.None Declared.

Synovial tissue features associated with poor prognosis in inflammatory arthritis

POS0010 PROTEOMIC LANDSCAPE OF SYNOVIAL TISSUE IN RHEUMATOID ARTHRITIS AND DETERMINANTS OF SYNOVIAL HISTOLOGICAL PATHOTYPES

High-grade synovitis associates with clinical markers and response to therapy in chronic inflammatory arthritis: post hoc analysis of a synovial biomarkers prospective cohort study

Immunophenotypic Landscape of synovial tissue in rheumatoid arthritis: Insights from ACPA status

New Proteins Contributing to Immune Cell Infiltration and Pannus Formation of Synovial Membrane from Arthritis Diseases

Proteins involved in the endoplasmic reticulum stress are modulated in synovitis of osteoarthritis, chronic pyrophosphate arthropathy and rheumatoid arthritis, and correlate with the histological inflammatory score

Higher Synovial Immunohistochemistry Reactivity of IL-17A, Dkk1, and TGF-β1 in Patients with Early Psoriatic Arthritis and Rheumatoid Arthritis Could Predict the Use of Biologics

Synovial inflammation in osteoarthritis progression

Increased synovial immunohistochemistry reactivity of TGF-β1 in erosive peripheral psoriatic arthritis

Characterization of the inflammatory proteome of synovial fluid from patients with psoriatic arthritis: Potential treatment targets

Vascular Synovial Phenotype Indicates Poor Response to JAK Inhibitors in Rheumatoid Arthritis Patients: a Pilot Study

POS0464 DIFFERENTIAL MOLECULAR PROFILES IN THE SYNOVIAL TISSUE AND SYNOVIAL FLUID OF PATIENTS WITH RHEUMATOID ARTHRITIS AND PSORIATIC ARTHRITIS

Distinct stromal and immune cell interactions shape the pathogenesis of rheumatoid and psoriatic arthritis

Differences in synovial fluid cytokine levels but not in synovial tissue cell infiltrate between anti-citrullinated peptide/protein antibody-positive and –negative rheumatoid arthritis patients

Senescent synovial fibroblasts accumulate prematurely in rheumatoid arthritis tissues and display an enhanced inflammatory phenotype

Cellular deconstruction of inflamed synovium defines diverse inflammatory phenotypes in rheumatoid arthritis

Clinical Phenotypes, Serological Biomarkers, and Synovial Features Defining Seropositive and Seronegative Rheumatoid Arthritis: A Literature Review

Clinical implications of synovial tissue phenotypes in rheumatoid arthritis

Persistence of power Doppler ultrasonography-detected synovitis over 1 year of follow-up predicts poor prognosis in rheumatoid arthritis in clinical remission: the SONORE prospective longitudinal study

Syndecans, Exostosins and Sulfotransferases as Potential Synovial Inflammation Moderators in Patients with Hip Osteoarthritis

Psoriatic Arthritis: Pathogenesis and Targeted Therapies